JavaScript отключён. Чтобы полноценно использовать наш сайт, включите JavaScript в своём браузере.

Ответить в теме

Сообщение: <blockquote data-quote="Morrissambit" data-source="post: 1112000" data-attributes="member: 85778">Avzj What my lockdown calls to an old man taught me about laughter, life 鈥?and myselfA recruitment firm that hires workers to conduct NHS Covid-19 tests 鈥?and is co-owned by a well-known football executive 鈥?has been supplying staff employed through a contrived network of companies that possesses many of the hallmarks of a notorious tax scam.Industrious Recruitment has  <a href="https://www.stanleycup.com.se">stanley mugg</a> supplied laborator <a href="https://www.stanley-quencher.us">stanley water jug</a> y staff to the Lighthouse laboratories in Milton Keynes, which was launched by the health secretary, Matt Hancock, last year as the first of three of the governments  mega labs  processing hundreds of thousands of Covid-19 tests a week.Hundreds of workers recruited by Industrious to process Covid-19 tests at the Department of Health-managed site have been employed by multiple companies, the Guardian understands, in a structure that appears to mimic schemes that have previously been cited as depriving the taxpayer of  hundreds of millions  of pounds a year.Tax dodging concerns over small firms used to pay NHS test-and-trace workersRead moreDays after the Guardian confronted Industrious about the <a href="https://www.cup-stanley.com.de">stanley kaffeebecher</a>  tax scheme, the Lighthouse lab workers said they had suddenly become directly employed by the recruitment company.Industrious is the latest recruitment firm that appears to have been supplying pandemic workers employed via mini umbrella companies  MUC . The problem was revealed by a Guardian investigation that has shown how the supply chain of the governments pandemic response seems to be riddled with such schemes.HM Revenue and Customs warned in December that  most MUC arrangements are Nozn Politically incorrect. Sorry about that : Madonna apologises for telling wheelchair user to stand at concertThe US supreme court will hear oral arguments next week to decide whether companies can patent human genes, in a landmark case which could alter the course of US medical research and the battle against diseases such as breast and ovarian cancer.A coalition of scientists, cancer survivors, patients, breast cancer groups and professional medical associations, which has brought the case, will argue that genes are  products of nature , like organs of the body and should not be exploited for commercial gain.Such patents are illegal and violate the first amendment, they say. They are challenging patents on two genes linked to breast and ovarian cancer owned by Myriad Genetics, a biotechnology company, because they say the patents have stymied research and the free exchange of ideas.Myriad, based in Salt Lake City, Utah, will ask the court to uphold the patents, which it says is vital compensation for developing a potentially life-sav <a href="https://www.cup-stanley-cup.pl">stanley butelka</a> ing test to asses the risks of breast and ovarian cancer and to advance medicin <a href="https://www.cups-stanley.de">stanley becher</a> e.聽Myriad s BRACAnalysis test looks for mutations on the breast cancer predisposition gene, or BRCA.In March 2010, a New York district court agreed with an American Civil Liberties Union challenge to Myriad s patents on  isolated  forms of BRCA1 and BRCA2, by arguing that genes should not be patented. But the US Court of Appeals for the federal court has now ruled twice that the isolated genes patented in Myriad s case has a  markedly different chemi <a href="https://www.cup-stanley-cup.de">stanley deutschland</a> c</blockquote>

Имя

Проверка